matrix m1

Vaccineexperimental

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07194668Phase 4Dec 1, 2025University of Oxford
NCT07183371Phase 2Nov 30, 2025European and Developing Countries Clinical Trials Partnership (EDCTP), European Vaccine Initiative (EVI), Heidelberg, Germany, Government of Germany, Institut et Haute école de la Santé, La Source, University of Oxford
NCT06958198Phase 1Sep 15, 2025European and Developing Countries Clinical Trials Partnership (EDCTP), European Vaccine Initiative (EVI), Heidelberg, Germany, Government of Germany, Institut et Haute école de la Santé, La Source, University of Oxford, Wellcome Trust
NCT07147400Phase 2Aug 22, 2025National Institute of Allergy and Infectious Diseases (NIAID), Serum Institute of India Pvt. Ltd.
NCT06816524N/AJul 1, 2025Jomo Kenyatta University of Agriculture and Technology, National Institute for Public Health and the Environment, RIVM, Holland, Radboud University, Swiss Federal Institute of Technology
NCT06080243Phase 2Feb 1, 2025European Vaccine Initiative (EVI), Heidelberg, Germany, Malaria Research and Training Center, Bamako, Mali, University of Oxford
NCT06482359Phase 2/Phase 3 (Phase 3)Nov 1, 2024Novavax
NCT06291857Phase 3Oct 21, 2024Novavax
NCT06320535Phase 1Mar 25, 2024Bill and Melinda Gates Foundation, University Hospitals Bristol NHS Foundation Trust, University of Oxford
NCT06068530Phase 4Nov 1, 2023Mahidol University, University of Oxford
NCT05683834Phase 1/Phase 2 (Phase 2)Sep 22, 2023National Institute of Allergy and Infectious Diseases (NIAID)
NCT05978037Phase 1/Phase 2 (Phase 2)Aug 18, 2023University of Oxford
NCT05913973Phase 1Aug 4, 2023National Institute of Allergy and Infectious Diseases (NIAID)
NCT06141057Phase 1Jun 6, 2023University of Oxford
NCT05790889Phase 1/Phase 2 (Phase 2)Apr 3, 2023European and Developing Countries Clinical Trials Partnership (EDCTP), Institut et Haute école de la Santé, La Source, University of Oxford, Wellcome Trust
NCT05875701Phase 3Mar 28, 2023Novavax
NCT05357560Phase 1Feb 28, 2023European and Developing Countries Clinical Trials Partnership (EDCTP), Medical Research Council, The Gambia, University of Oxford
NCT05519839Phase 2Jan 16, 2023Novavax
NCT05400746Early Phase 1 (Phase 1)Nov 2, 2022University of Oxford
NCT05385471Early Phase 1 (Phase 1)Nov 1, 2022Churchill Hospital, Oxford, University of Oxford
Showing 20 of 61 trials
Page 1 / 4

Organizations

Research & Development (41)

41 organizations
Page 1 / 3